Vernalis' collaboration with Tris Latest status of the programmes for the US prescription market.
See at a glance what Vernalis has in development See the status of all programmes,…
Vernalis Research is a world leader in structure- and fragment-based drug discovery.
30 June, 2017 Results
Download our latest report...
14 December, 2017
Our latest presentation is available to view from here...
Share price: 6.24pChange: -0.01 (-0.16%)As at: 17 August 2018 15:21:00Volume: 22,034,534LSE ID: VER
Share price details
T: 0118 938 0000 F: 0118 938 0001Contact informationMaps and directionsContact form
To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and firstname.lastname@example.org or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch